393 related articles for article (PubMed ID: 32678196)
1. Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma.
Bolidong D; Domoto T; Uehara M; Sabit H; Okumura T; Endo Y; Nakada M; Ninomiya I; Miyashita T; Wong RW; Minamoto T
Sci Rep; 2020 Jul; 10(1):11807. PubMed ID: 32678196
[TBL] [Abstract][Full Text] [Related]
2. Glycogen synthase kinase 3β as a potential therapeutic target in synovial sarcoma and fibrosarcoma.
Abe K; Yamamoto N; Domoto T; Bolidong D; Hayashi K; Takeuchi A; Miwa S; Igarashi K; Inatani H; Aoki Y; Higuchi T; Taniguchi Y; Yonezawa H; Araki Y; Aiba H; Minamoto T; Tsuchiya H
Cancer Sci; 2020 Feb; 111(2):429-440. PubMed ID: 31808966
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of glycogen synthase kinase 3 beta (GSK3β) suppresses the progression of esophageal squamous cell carcinoma by modifying STAT3 activity.
Gao S; Li S; Duan X; Gu Z; Ma Z; Yuan X; Feng X; Wang H
Mol Carcinog; 2017 Oct; 56(10):2301-2316. PubMed ID: 28574599
[TBL] [Abstract][Full Text] [Related]
4. Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo.
Liu X; Song M; Wang P; Zhao R; Chen H; Zhang M; Shi Y; Liu K; Liu F; Yang R; Li E; Bode AM; Dong Z; Lee MH
Int J Cancer; 2019 Aug; 145(4):1007-1019. PubMed ID: 30887517
[TBL] [Abstract][Full Text] [Related]
5. Long non‑coding RNA MEG3 suppresses epithelial‑to‑mesenchymal transition by inhibiting the PSAT1‑dependent GSK‑3β/Snail signaling pathway in esophageal squamous cell carcinoma.
Li MK; Liu LX; Zhang WY; Zhan HL; Chen RP; Feng JL; Wu LF
Oncol Rep; 2020 Nov; 44(5):2130-2142. PubMed ID: 32901893
[TBL] [Abstract][Full Text] [Related]
6. Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinoma.
Qie S; Yoshida A; Parnham S; Oleinik N; Beeson GC; Beeson CC; Ogretmen B; Bass AJ; Wong KK; Rustgi AK; Diehl JA
Nat Commun; 2019 Mar; 10(1):1296. PubMed ID: 30899002
[TBL] [Abstract][Full Text] [Related]
7. CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest.
Wang J; Li Q; Yuan J; Wang J; Chen Z; Liu Z; Li Z; Lai Y; Gao J; Shen L
J Transl Med; 2017 Jun; 15(1):127. PubMed ID: 28578693
[TBL] [Abstract][Full Text] [Related]
8. Deoxypodophyllotoxin, a Lignan from
Kwak AW; Lee MH; Yoon G; Cho SS; Choi JS; Chae JI; Shim JH
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961992
[TBL] [Abstract][Full Text] [Related]
9. TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src/GSK3β/STAT3 signaling pathway via γ-catenin.
Jiang Y; Zhang J; Zhao J; Li Z; Chen H; Qiao Y; Chen X; Liu K; Dong Z
BMC Cancer; 2019 Dec; 19(1):1264. PubMed ID: 31888532
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y
FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565
[TBL] [Abstract][Full Text] [Related]
11. circGSK3β promotes metastasis in esophageal squamous cell carcinoma by augmenting β-catenin signaling.
Hu X; Wu D; He X; Zhao H; He Z; Lin J; Wang K; Wang W; Pan Z; Lin H; Wang M
Mol Cancer; 2019 Nov; 18(1):160. PubMed ID: 31722716
[TBL] [Abstract][Full Text] [Related]
12. Antitumour effects of artesunate via cell cycle checkpoint controls in human oesophageal squamous carcinoma cells.
Mao L; Deng G; Li M; Lu SH; Jiang W; Yu X
Eur J Med Res; 2024 May; 29(1):293. PubMed ID: 38773551
[TBL] [Abstract][Full Text] [Related]
13. CDK11
Du Y; Yan D; Yuan Y; Xu J; Wang S; Yang Z; Cheng W; Tian X; Kan Q
Cell Cycle; 2019 Feb; 18(4):452-466. PubMed ID: 30722725
[TBL] [Abstract][Full Text] [Related]
14. Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.
Ma S; Bao JYJ; Kwan PS; Chan YP; Tong CM; Fu L; Zhang N; Tong AHY; Qin YR; Tsao SW; Chan KW; Lok S; Guan XY
Gastroenterology; 2012 Sep; 143(3):675-686.e12. PubMed ID: 22705009
[TBL] [Abstract][Full Text] [Related]
15. TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines.
Jiang YY; Jiang Y; Li CQ; Zhang Y; Dakle P; Kaur H; Deng JW; Lin RY; Han L; Xie JJ; Yan Y; Doan N; Zheng Y; Mayakonda A; Hazawa M; Xu L; Li Y; Aswad L; Jeitany M; Kanojia D; Guan XY; Said JW; Yang W; Fullwood MJ; Lin DC; Koeffler HP
Gastroenterology; 2020 Oct; 159(4):1311-1327.e19. PubMed ID: 32619460
[TBL] [Abstract][Full Text] [Related]
16. Isoliquiritigenin Suppressed Esophageal Squamous Carcinoma Growth by Blocking EGFR Activation and Inducing Cell Cycle Arrest.
Ye L; Zhang J; Zhang Y; Gu B; Zhu H; Mao X
Biomed Res Int; 2020; 2020():9259852. PubMed ID: 32190688
[TBL] [Abstract][Full Text] [Related]
17. Macrophage migration inhibitory factor promotes tumor aggressiveness of esophageal squamous cell carcinoma via activation of Akt and inactivation of GSK3β.
Liu RM; Sun DN; Jiao YL; Wang P; Zhang J; Wang M; Ma J; Sun M; Gu BL; Chen P; Liu K; Ma H; Gao SG; Ma YF; Qi YJ
Cancer Lett; 2018 Jan; 412():289-296. PubMed ID: 29079416
[TBL] [Abstract][Full Text] [Related]
18. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
[TBL] [Abstract][Full Text] [Related]
19. GSK3β-driven SOX2 overexpression is a targetable vulnerability in esophageal squamous cell carcinoma.
Kang L; Liu Y; He J; Wang Y; Xue M; Wu X; Wang Z; Zhang Y; Chu M; Li J; Wei W; Li J; Li E; Liao L; Xiao J; Zhang R; Xu L; Wong J
Oncogene; 2023 Jul; 42(30):2297-2314. PubMed ID: 37349645
[TBL] [Abstract][Full Text] [Related]
20. ACP-5862 suppresses esophageal squamous cell carcinoma growth through inducing apoptosis via activation of endoplasmic reticulum stress and ROS production.
Liu Q; He J; Zhou X; Han M; Li J; Liu C; Yuan H
Biochem Biophys Res Commun; 2021 Jan; 534():995-1002. PubMed ID: 33168189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
